Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

Lalida Rojanathammanee1, Eric J Murphy, Colin K Combs

  • 1Department of Pharmacology, Physiology, & Therapeutics, University of North Dakota School of Medicine and Health Sciences, 504 Hamline Street, Neuroscience Building, Grand Forks, ND 58203, USA.

Abstract

Insights

Over-expressing alpha-synuclein (α-synuclein) in microglia triggers a reactive inflammatory state, increasing pro-inflammatory cytokines and impairing phagocytosis. This suggests a role for α-synuclein in Parkinson's disease pathology.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Reactive microglia and alpha-synuclein (α-synuclein) protein deposits are hallmarks of Parkinson's disease (PD).
  • Microglial inflammation is implicated in PD pathogenesis, with mutations in α-synuclein linked to familial PD.
  • Prior studies indicate α-synuclein regulates microglial phenotype, prompting investigation into mutant forms' role in PD-associated microgliosis.

Purpose of the Study:

  • To investigate how wild type and mutant α-synuclein expression affects microglial cell phenotype.
  • To determine if α-synuclein overexpression influences inflammatory markers, phagocytic capacity, and neurotoxicity in microglia.

Main Methods:

  • Murine microglial cell line (BV2) was transiently transfected with human wild type (WT), A30P, and A53T mutant α-synuclein.
  • Assessed microglial phenotype changes using Western blot, ELISA, phagocytosis assays, and neurotoxicity assays.

Main Results:

  • Overexpression of α-synuclein induced a reactive microglial phenotype, increasing cyclooxygenase-2 (Cox-2) levels.
  • Transfected cells showed elevated secretion of pro-inflammatory cytokines (TNF-α, IL-6) and nitric oxide production.
  • Phagocytic ability was impaired, evidenced by decreased lysosomal-associated membrane protein 1 (LAMP-1) levels, but neurotoxicity did not increase.

Conclusions:

  • Overexpression of α-synuclein induces a reactive microglial phenotype characterized by increased inflammatory mediator secretion and impaired phagocytosis.
  • These findings highlight a potential mechanism by which α-synuclein contributes to neuroinflammation in Parkinson's disease.

Related Concept Videos